
Walter E. Webb
Examiner (ID: 8444, Phone: (571)270-3287 , Office: P/1612 )
| Most Active Art Unit | 1612 |
| Art Unit(s) | 4133, 1612 |
| Total Applications | 1244 |
| Issued Applications | 565 |
| Pending Applications | 114 |
| Abandoned Applications | 592 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 7111750
[patent_doc_number] => 20050209206
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-22
[patent_title] => 'Pharmaceutical formulation comprising an androstane derivative and a solubilising agent in an aqueous liquid carrier'
[patent_app_type] => utility
[patent_app_number] => 10/503000
[patent_app_country] => US
[patent_app_date] => 2003-02-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 10940
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0209/20050209206.pdf
[firstpage_image] =>[orig_patent_app_number] => 10503000
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/503000 | Pharmaceutical formulation comprising an androstane derivative and a solubilising agent in an aqueous liquid carrier | Feb 3, 2003 | Abandoned |
Array
(
[id] => 7200332
[patent_doc_number] => 20050164996
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-07-28
[patent_title] => 'Pharmaceutical formulation comprising an aqueous suspension of an androstane derivative for the treatment of inflammatory and allergic conditions'
[patent_app_type] => utility
[patent_app_number] => 10/502902
[patent_app_country] => US
[patent_app_date] => 2003-02-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 9577
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0164/20050164996.pdf
[firstpage_image] =>[orig_patent_app_number] => 10502902
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/502902 | Pharmaceutical formulation comprising an aqueous suspension of an androstane derivative for the treatment of inflammatory and allergic conditions | Feb 3, 2003 | Abandoned |
Array
(
[id] => 239612
[patent_doc_number] => 07592329
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-09-22
[patent_title] => 'Crystalline complexes of fluticasone-2-furoate'
[patent_app_type] => utility
[patent_app_number] => 10/503114
[patent_app_country] => US
[patent_app_date] => 2003-02-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 36
[patent_figures_cnt] => 36
[patent_no_of_words] => 23501
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/592/07592329.pdf
[firstpage_image] =>[orig_patent_app_number] => 10503114
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/503114 | Crystalline complexes of fluticasone-2-furoate | Feb 3, 2003 | Issued |
Array
(
[id] => 6982775
[patent_doc_number] => 20050152845
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-07-14
[patent_title] => 'Amorphous fluticasone 2-furoate, pharmaceutical compositions thereof and its conversion to the crystalline unsolvated form'
[patent_app_type] => utility
[patent_app_number] => 10/503394
[patent_app_country] => US
[patent_app_date] => 2003-02-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 12737
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0152/20050152845.pdf
[firstpage_image] =>[orig_patent_app_number] => 10503394
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/503394 | Amorphous fluticasone 2-furoate, pharmaceutical compositions thereof and its conversion to the crystalline unsolvated form | Feb 3, 2003 | Abandoned |
Array
(
[id] => 7020088
[patent_doc_number] => 20050222107
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-10-06
[patent_title] => 'Novel process'
[patent_app_type] => utility
[patent_app_number] => 10/502866
[patent_app_country] => US
[patent_app_date] => 2003-02-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8949
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0222/20050222107.pdf
[firstpage_image] =>[orig_patent_app_number] => 10502866
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/502866 | Novel process | Feb 2, 2003 | Abandoned |
Array
(
[id] => 7256710
[patent_doc_number] => 20050143388
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-06-30
[patent_title] => 'Nitric oxide donors for treatment of disease and injury'
[patent_app_type] => utility
[patent_app_number] => 10/500694
[patent_app_country] => US
[patent_app_date] => 2003-01-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 18515
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0143/20050143388.pdf
[firstpage_image] =>[orig_patent_app_number] => 10500694
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/500694 | Nitric oxide donors for treatment of disease and injury | Jan 5, 2003 | Abandoned |
Array
(
[id] => 5700630
[patent_doc_number] => 20060217315
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-09-28
[patent_title] => 'Method of controlled ovarian hyperstimulation and pharmaceutical kit for use in such method'
[patent_app_type] => utility
[patent_app_number] => 10/499505
[patent_app_country] => US
[patent_app_date] => 2002-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6510
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0217/20060217315.pdf
[firstpage_image] =>[orig_patent_app_number] => 10499505
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/499505 | Method of controlled ovarian hyperstimulation and pharmaceutical kit for use in such method | Dec 19, 2002 | Abandoned |
Array
(
[id] => 5814823
[patent_doc_number] => 20060084612
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-04-20
[patent_title] => 'Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and protein kinase (serine/threonine kinase) inhibitors'
[patent_app_type] => utility
[patent_app_number] => 10/500606
[patent_app_country] => US
[patent_app_date] => 2002-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2298
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0084/20060084612.pdf
[firstpage_image] =>[orig_patent_app_number] => 10500606
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/500606 | Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and protein kinase (serine/threonine kinase) inhibitors | Dec 17, 2002 | Abandoned |
Array
(
[id] => 4697751
[patent_doc_number] => 20080219935
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-09-11
[patent_title] => 'Phase Transitive Breath Care Products'
[patent_app_type] => utility
[patent_app_number] => 11/994970
[patent_app_country] => US
[patent_app_date] => 2002-07-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5149
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0219/20080219935.pdf
[firstpage_image] =>[orig_patent_app_number] => 11994970
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/994970 | Phase Transitive Breath Care Products | Jul 6, 2002 | Abandoned |
Array
(
[id] => 4566511
[patent_doc_number] => 07846957
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-12-07
[patent_title] => 'Aromatase inhibition to enhance assisted reproduction'
[patent_app_type] => utility
[patent_app_number] => 10/475172
[patent_app_country] => US
[patent_app_date] => 2002-04-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14744
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 119
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/846/07846957.pdf
[firstpage_image] =>[orig_patent_app_number] => 10475172
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/475172 | Aromatase inhibition to enhance assisted reproduction | Apr 16, 2002 | Issued |
Array
(
[id] => 7151271
[patent_doc_number] => 20040171660
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-09-02
[patent_title] => 'Single dose aromatase inhibitor for treating infertility'
[patent_app_type] => new
[patent_app_number] => 10/475101
[patent_app_country] => US
[patent_app_date] => 2004-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15260
[patent_no_of_claims] => 79
[patent_no_of_ind_claims] => 65
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0171/20040171660.pdf
[firstpage_image] =>[orig_patent_app_number] => 10475101
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/475101 | Single dose aromatase inhibitor for treating infertility | Apr 16, 2002 | Issued |
Array
(
[id] => 7004684
[patent_doc_number] => 20050169997
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-08-04
[patent_title] => 'Method for preparing resinates'
[patent_app_type] => utility
[patent_app_number] => 10/501765
[patent_app_country] => US
[patent_app_date] => 2002-01-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6396
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0169/20050169997.pdf
[firstpage_image] =>[orig_patent_app_number] => 10501765
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/501765 | Method for preparing resinates | Jan 17, 2002 | Abandoned |
Array
(
[id] => 5632262
[patent_doc_number] => 20060148732
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-07-06
[patent_title] => 'Inhibition of NF-kappaB by triterpene compositions'
[patent_app_type] => utility
[patent_app_number] => 09/992556
[patent_app_country] => US
[patent_app_date] => 2001-11-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 55
[patent_figures_cnt] => 55
[patent_no_of_words] => 87518
[patent_no_of_claims] => 55
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0148/20060148732.pdf
[firstpage_image] =>[orig_patent_app_number] => 09992556
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/992556 | Inhibition of NF-kappaB by triterpene compositions | Nov 15, 2001 | Abandoned |